GHRP-2 (pralmorelin) is a synthetic growth hormone releasing peptide that acts as a ghrelin receptor agonist, prompting the pituitary gland to release more of the body's own growth hormone. It is researched for short pulses of GH secretion rather than replacing the hormone directly, and is often studied alongside a GHRH analogue such as CJC-1295. GHRP-2 is a research-stage peptide, not approved by the FDA. At Menscape Clinic in Bangkok it may be prescribed off-label and compounded by a licensed pharmacy partner under medical supervision.
/)
Medically reviewed by Dr. Tuksaorn Suriyakan (Ping), Anti-Aging & Regenerative Medicine Physician
8 years of experience
Our solutions for Anti-Aging & Vitality
Indications evaluated in research, listed in order of current evidence weight. Suitability is determined case-by-case.
GHRP-2, also known as pralmorelin, is a synthetic hexapeptide first developed in growth hormone research decades ago. It belongs to a family called growth hormone secretagogues, which prompt the body to release more of its own growth hormone instead of supplying the hormone directly. Internationally it has one narrow regulatory role: in Japan it was approved in 2004 as a diagnostic agent for assessing growth hormone deficiency. It is not approved by the FDA for treatment, and most uses discussed here are research-stage. At Menscape Clinic in Bangkok, GHRP-2 may be prescribed off-label and compounded by a licensed pharmacy partner under medical supervision.
/)
GHRP-2 binds to the ghrelin receptor (GHS-R1a) in the pituitary and hypothalamus, the same receptor activated by the natural hunger hormone ghrelin. This signals the pituitary to release a pulse of growth hormone, which in turn raises IGF-1, a messenger linked to repair and protein synthesis. Because it works through your own pituitary, it tends to preserve the natural pulsing pattern of GH. It is frequently studied stacked with a GHRH analogue such as CJC-1295, since the two pathways together can produce a markedly larger GH response than either alone.
/)
GHRP-2 is explored by adults interested in growth hormone optimisation, recovery, body composition and age-related decline in GH output. Because it is research-stage and acts on the ghrelin pathway, it is not suitable for everyone. It is generally avoided in anyone with active or past cancer, and it is not appropriate during pregnancy or breastfeeding. Men with diabetes, prolactin-sensitive conditions or significant hormonal imbalance need careful assessment first. A Menscape physician reviews your history, goals and bloodwork before deciding whether GHRP-2 is reasonable to consider.
/)
At Menscape Clinic in Bangkok, GHRP-2 is never sold as an off-the-shelf product. It starts with a consultation and baseline labs, including IGF-1 where relevant. If a physician judges it appropriate, it is prescribed off-label and compounded by a licensed pharmacy partner, typically as a small subcutaneous injection. Dosing is individualised and monitored, often with prolactin and metabolic markers tracked over time, and it may be reviewed alongside other peptides such as CJC-1295. Our English-speaking team supports international and medical-tourism patients throughout follow-up.
/)
Every GHRP-2 protocol starts with a full medical consultation and history review.
Prescriptions are filled by a licensed compounding pharmacy partner, not over-the-counter.
Follow-up consultations every four to six weeks to assess response and safety.
We frame GHRP-2 as a research-stage option and prescribe only when clinically appropriate.
GHRP-2 is not approved by the FDA for treatment. Its only formal approval is in Japan, where it was cleared in 2004 as a diagnostic agent for growth hormone deficiency, not as a therapy. In a clinical setting it is handled as a research-stage peptide that may be prescribed off-label and compounded by a licensed pharmacy partner under medical supervision. At Menscape Clinic in Bangkok it is only ever provided after a physician consultation, never sold directly.
It is studied mainly for stimulating the body's own growth hormone, with downstream interest in recovery, tissue repair, body composition, appetite and sleep. These are areas of research and individual exploration rather than confirmed, approved treatments. Human outcome data in healthy adults is limited, which is why we keep expectations conservative and monitor closely.
Synthetic growth hormone adds the hormone from outside the body. GHRP-2 instead signals your own pituitary to release a pulse of GH, which tends to preserve the natural rhythm of secretion. Because the response depends on your own physiology, it is generally more measured than injecting GH directly, though it is still researched rather than proven for these purposes.
It is often studied alongside CJC-1295, a GHRH analogue, because the two work through different pathways. Combined, they can produce a notably larger growth hormone response than either peptide alone. Whether a stack is appropriate for you is a clinical decision made by a Menscape physician based on your goals and labs.
Because it activates the ghrelin receptor, GHRP-2 may increase appetite and can raise prolactin and cortisol, especially at higher doses. Reported effects include water retention, tingling or numbness, headache, head rush, and changes in insulin sensitivity. Sustained high prolactin has been linked to breast tissue changes in men. This is why dosing is individualised and monitored, and why it is not suitable for everyone.
Access begins with a medical consultation and baseline labs, not an online purchase. If a physician judges GHRP-2 reasonable for your situation, it may be prescribed off-label and compounded by a licensed pharmacy partner, then monitored over time. Our English-speaking team is set up for international and medical-tourism patients who want supervised, conservative care.
/)
Dr. Tuksaorn (Dr. Ping) is an anti-aging and regenerative medicine physician with over 8 years of experience, focused on evidence-based wellness and personalized health programs that combine modern medical science with individualized care.
/)
/)
/)
/)
/)